Real-world evaluation of compliance and preference in Alzheimer's disease treatment

Pai, Ming-Chyi ; Aref, Hany ; Bassil, Nazem ; Kandiah, Nagaendran ; Lee, Jae-Hong ; Srinivasan, A V ; diTommaso, Shelley ; Yuksel, Ozgur 


Abstract


Rivastigmine transdermal patch has shown higher caregiver satisfaction and greater preference than oral formulation in patients with Alzheimer's disease. However, there is limited literature available related to caregiver preference or treatment compliance in real-world clinical settings. To date, no such data are available from Asia and the Middle East, which account for a sizeable proportion of patients with Alzheimer's disease. The objective of this study was to evaluate treatment preference and compliance with oral and transdermal medications in daily clinical practice in an ethnically diverse patient population from Asia and the Middle East with mild-to-moderate Alzheimer's disease.


Other data

Issue Date 2015
Journal Clinical interventions in aging 
URI http://research.asu.edu.eg/handle/123456789/1850
DOI 1779-87
10
1178-1998
10.2147/CIA.S85319


Recommend this item

CORE Recommender
4
Citations

5
Views


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.